Literature DB >> 28515471

Clinical and molecular investigation of 14 Japanese patients with complete TFP deficiency: a comparison with Caucasian cases.

Ryosuke Bo1,2, Kenji Yamada1, Hironori Kobayashi1, Purevsuren Jamiyan3, Yuki Hasegawa1, Takeshi Taketani1, Seiji Fukuda1, Ikue Hata4, Yo Niida5, Yosuke Shigematsu4, Kazumoto Iijima2, Seiji Yamaguchi1.   

Abstract

Mitochondrial trifunctional protein (TFP) deficiency is an inherited metabolic disorder of mitochondrial fatty-acid oxidation. Isolated long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency is often reported in Caucasian countries due to a common mutation. However, the molecular and clinical basis of complete TFP deficiency has not been extensively reported. In this study, 14 Japanese cases (13 families) with complete TFP deficiency, including 9 previously reported cases, were analyzed to clarify the clinical and molecular characteristics of TFP deficiency. The clinical types of the 14 patients were as follows: 12 cases of neonatal (n=7) or myopathic (n=5) types and 2 cases of intermediate type. Peripheral neuropathy was found in four cases and hypocalcemia due to hypoparathyroidism, which is rarely reported in Caucasian patients, had developed in four cases. Maternal hemolysis, elevated liver enzymes and low platelet count syndrome and acute fatty liver of pregnancy were noted in two and one mothers, respectively. Fourteen mutations were identified in 26 alleles in Japanese patients, including two novel mutations (HADHA: c.361C>T, and HADHA-HADHB: g.26233880_ 26248855del), although no common mutations were found. This study suggests that the molecular and clinical aspects of Japanese patients with TFP deficiencies differ from those of Caucasian patients.

Entities:  

Mesh:

Substances:

Year:  2017        PMID: 28515471     DOI: 10.1038/jhg.2017.52

Source DB:  PubMed          Journal:  J Hum Genet        ISSN: 1434-5161            Impact factor:   3.172


  34 in total

1.  Long-chain 3-hydroxyacyl-CoA dehydrogenase deficiency: identification of a new inborn error of mitochondrial fatty acid beta-oxidation.

Authors:  R J Wanders; L IJlst; A H van Gennip; C Jakobs; J P de Jager; L Dorland; F J van Sprang; M Duran
Journal:  J Inherit Metab Dis       Date:  1990       Impact factor: 4.982

2.  Mitochondrial trifunctional protein deficiency in human cultured fibroblasts: effects of bezafibrate.

Authors:  Fatima Djouadi; Florence Habarou; Carole Le Bachelier; Sacha Ferdinandusse; Dimitri Schlemmer; Jean François Benoist; Audrey Boutron; Brage S Andresen; Gepke Visser; Pascale de Lonlay; Simon Olpin; Toshiyuki Fukao; Seiji Yamaguchi; Arnold W Strauss; Ronald J A Wanders; Jean Bastin
Journal:  J Inherit Metab Dis       Date:  2015-06-25       Impact factor: 4.982

Review 3.  Observations regarding retinopathy in mitochondrial trifunctional protein deficiencies.

Authors:  Autumn L Fletcher; Mark E Pennesi; Cary O Harding; Richard G Weleber; Melanie B Gillingham
Journal:  Mol Genet Metab       Date:  2012-03-08       Impact factor: 4.797

4.  Comprehensive cDNA study and quantitative analysis of mutant HADHA and HADHB transcripts in a French cohort of 52 patients with mitochondrial trifunctional protein deficiency.

Authors:  A Boutron; C Acquaviva; C Vianey-Saban; P de Lonlay; H Ogier de Baulny; N Guffon; D Dobbelaere; F Feillet; F Labarthe; D Lamireau; A Cano; T Billette de Villemeur; A Munnich; J M Saudubray; D Rabier; O Rigal; M Brivet
Journal:  Mol Genet Metab       Date:  2011-04-19       Impact factor: 4.797

5.  The enzymology of mitochondrial fatty acid beta-oxidation and its application to follow-up analysis of positive neonatal screening results.

Authors:  Ronald J A Wanders; Jos P N Ruiter; Lodewijk IJLst; Hans R Waterham; Sander M Houten
Journal:  J Inherit Metab Dis       Date:  2010-05-20       Impact factor: 4.982

6.  Mitochondrial trifunctional protein deficiency: a severe fatty acid oxidation disorder with cardiac and neurologic involvement.

Authors:  Margarethe E J den Boer; Carlo Dionisi-Vici; Anupam Chakrapani; Anders O J van Thuijl; Ronald J A Wanders; Frits A Wijburg
Journal:  J Pediatr       Date:  2003-06       Impact factor: 4.406

7.  Bezafibrate can be a new treatment option for mitochondrial fatty acid oxidation disorders: evaluation by in vitro probe acylcarnitine assay.

Authors:  Seiji Yamaguchi; Hong Li; Jamiyan Purevsuren; Kenji Yamada; Midori Furui; Tomoo Takahashi; Yuichi Mushimoto; Hironori Kobayashi; Yuki Hasegawa; Takeshi Taketani; Toshiyuki Fukao; Seiji Fukuda
Journal:  Mol Genet Metab       Date:  2012-07-14       Impact factor: 4.797

8.  The early-onset phenotype of mitochondrial trifunctional protein deficiency: a lethal disorder with multiple tissue involvement.

Authors:  U Spierkerkoetter; Z Khuchua; Z Yue; A W Strauss
Journal:  J Inherit Metab Dis       Date:  2004       Impact factor: 4.982

9.  Clinical and molecular aspects of Japanese patients with mitochondrial trifunctional protein deficiency.

Authors:  Jamiyan Purevsuren; Toshiyuki Fukao; Yuki Hasegawa; Hironori Kobayashi; Hong Li; Yuichi Mushimoto; Seiji Fukuda; Seiji Yamaguchi
Journal:  Mol Genet Metab       Date:  2009-07-23       Impact factor: 4.797

10.  Mitochondrial trifunctional protein deficiency due to HADHB gene mutation in a Chinese family.

Authors:  Xiaona Fu; Feixia Zheng; Yao Zhang; Xinhua Bao; Shuang Wang; Yanling Yang; Hui Xiong
Journal:  Mol Genet Metab Rep       Date:  2015-11-06
View more
  7 in total

Review 1.  Management and diagnosis of mitochondrial fatty acid oxidation disorders: focus on very-long-chain acyl-CoA dehydrogenase deficiency.

Authors:  Kenji Yamada; Takeshi Taketani
Journal:  J Hum Genet       Date:  2018-11-06       Impact factor: 3.172

Review 2.  Impact of newborn screening on the reported incidence and clinical outcomes associated with medium- and long-chain fatty acid oxidation disorders.

Authors:  Deborah Marsden; Camille L Bedrosian; Jerry Vockley
Journal:  Genet Med       Date:  2021-01-25       Impact factor: 8.822

3.  Evaluation of earlier versus later dietary management in long-chain 3-hydroxyacyl-CoA dehydrogenase or mitochondrial trifunctional protein deficiency: a systematic review.

Authors:  Hannah Fraser; Julia Geppert; Rebecca Johnson; Samantha Johnson; Martin Connock; Aileen Clarke; Sian Taylor-Phillips; Chris Stinton
Journal:  Orphanet J Rare Dis       Date:  2019-11-15       Impact factor: 4.123

4.  Novel HADHB mutations in a patient with mitochondrial trifunctional protein deficiency.

Authors:  Mina Nakama; Hideo Sasai; Mitsuru Kubota; Yuki Hasegawa; Ryoji Fujiki; Torayuki Okuyama; Osamu Ohara; Toshiyuki Fukao
Journal:  Hum Genome Var       Date:  2020-04-02

5.  Recurrent metabolic alkalosis following ketone body treatment of adult mitochondrial trifunctional protein deficiency: A case report.

Authors:  Nina N Stolwijk; Mirjam Langeveld; Bart A W Jacobs; Liffert Vogt; Jorien A Haverkamp; Sacha Ferdinandusse; Carla E M Hollak
Journal:  JIMD Rep       Date:  2022-06-25

6.  Expanding the genotype-phenotype correlation of childhood sensory polyneuropathy of genetic origin.

Authors:  Samya Chakravorty; Rachel Logan; Molly J Elson; Rebecca R Luke; Sumit Verma
Journal:  Sci Rep       Date:  2020-09-30       Impact factor: 4.379

7.  Analysis of a family with mitochondrial trifunctional protein deficiency caused by HADHA gene mutations.

Authors:  Jinling Yang; Dejian Yuan; Xiaohui Tan; Yexi Zeng; Ning Tang; Dayu Chen; Jianqiang Tan; Ren Cai; Jun Huang; Tizhen Yan
Journal:  Mol Med Rep       Date:  2021-12-08       Impact factor: 2.952

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.